ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SFX‐01 to enter Phase II/III trials to test efficacy against COVID-19 symptoms
June 19, 2020The drug candidate SFX-01 is set to be studied in Phase II/III trials to test its efficacy at treating acute respiratory distress syndrome (ARDS), a complication of COVID‐19. -
Evgen's SFX-01 selected for COVID-19 trial
June 18, 2020Evgen Pharma's lead candidate SFX-01 has been selected for evaluation in a randomised Phase II/III trial, to be sponsored by the University of Dundee, which aims to investigate its potential as a treatment for COVID-19.
Pharma Sources Insight January 2025
